Semi-annual Performance Forecast for 2026
Filed with SSE · · 2 pages · Chinese
Guizhou Yibai Pharmaceutical Co. Ltd. on 6ix
Earlier from Guizhou Yibai Pharmaceutical
- Announcement on Inclusion of the Company's Pharmaceutical Products in the "National Essential Medicines List (2026 Edition)"
- Announcement on the Cancellation of Repurchased Shares and the Change in Share Capital
- Announcement on Election of Employee Representative Director
- Announcement on Resolutions of the 17th Meeting of the 8th Board of Directors
- Announcement on Changing the Use of Shares Repurchased and Cancellation and Notice to Creditors
Later from Guizhou Yibai Pharmaceutical
- Announcement on the Receipt of the "Administrative Penalty Notice" from Guizhou Provincial Drug Administration
- Announcement on the Selection of Products in the Second Round of Follow-Up Centralized Procurement by the National Alliance for Chinese Patent Medicine Procurement
- Announcement on Resolutions of the 2nd Meeting of the 9th Board of Directors
Follow Guizhou Yibai Pharmaceutical into a list and get an email when it puts out news.
Follow Guizhou Yibai Pharmaceutical